This narrative review synthesizes current literature on PH, detailing its mechanisms, risk factors, diagnostic methods, and management strategies, ultimately emphasizing the need for individualized and multidisciplinary approaches to improve patient outcomes as the incidence of PH is expected to rise with the increasing prevalence of upper GI surgeries
Secondary outcomes such as pharmacokinetic measurements (e.g., Cmax) and the assessment of CT-996's interaction with a high-fat meal are appropriate for understanding the drugs absorption, distribution, metabolism, and excretion (ADME) profile
Additionally, the psychological aspects of BEDincluding emotional regulation difficulties and the functional role of binge eatingmay not be adequately addressed by medication alone
Fatty liver disease often develops when the body struggles to process fats and sugars efficiently
Blood clots are semi-solid lumps of blood cells stuck together